Where Global Innovation
and Capital Meet
Sectors ConsumerUniversityEnergyFinancialHealthcareIndustrialITMediaServicesTelecomsTransportThe Art of CVCStartups

Page 310

Editorial: Management approaches to portfolio

Given the rise of intangibles in the economy, control versus delegation strikes at the heart of modern business practices. If or whether both Tencent and Alibaba continue to perform as well in the future might reflect their approaches in management.

Apr 2, 2018

Advanced camera producer Lytro shutters business

Lytro, which had raised more than $200m from investors including Qualcomm, Foxconn and Huayi Brothers, has closed.

Mar 30, 2018

Strider reaches Syngenta

Qualcomm Ventures has exited agricultural management platform developer Strider in an acquisition of undisclosed size by Syngenta.

Mar 30, 2018

DocuSign to dovetail to public markets

The digital signature technology provider, backed by Dell, Intel, Salesforce, Telstra, Visa, Deutsche Telekom, Samsung, NTT, Mitsui, BBVA, Alphabet and Comcast, has filed for a $100m IPO.

Mar 29, 2018

Bilibili bullets to $483m IPO

The online entertainment platform, which counts Tencent and Legend Capital among its investors, priced its initial public offering in the middle of its range.

Mar 29, 2018

iQiyi to broadcast $2.25bn IPO

The online video streaming platform, which is majority owned by Baidu, has priced its shares in the middle of its range and will have a $14.5bn market cap.

Mar 29, 2018

Snap draws up PlayCanvas acquisition

DC Thomson Ventures led the 3D game development platform's seed round four years ago, and has exited through an acquisition by Snap.

Mar 28, 2018

Inke signs IPO filing

Tencent, Kunlun, Duomi and Shunya-backed video broadcasting app Inke has filed to go public after raising some $65m in funding.

Mar 28, 2018

Surface IPO targets $75m

Novartis, Eli Lilly and Amgen-backed cancer immunotherapy developer Surface Oncology has filed for a $75m offering on Nasdaq.

Mar 28, 2018

Aslan aligns itself with $86m IPO

Biopharmaceuticals developer Aslan Pharmaceuticals, which counts AMT, Accuron and Tianda as backers, has filed to raise up to $86.3m in an initial public offering.

Mar 28, 2018
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here